Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

"Between the warrants and the Lincoln Park Capital equity funding facility, the Company has approximately $25 million in additional funding available, which the Company believes would fund operations until at least deep into 2016, however there is no assurance that the warrants will be exercised or that we will be able to fully draw from the Lincoln Park facility."

Reason for AS Increase Vote:

"As of this date, however, the Company requires additional authorized shares to assure the capital markets and investors that the Company has adequate common shares available to complete M&A activity if an attractive opportunity presents itself, raise additional funds if needed, and offer adequate equity compensation to enable recruitment of the best talent the Company will be seeking to bring on full-time as employees. The Company has been advised by various stakeholders in the larger capital markets community that it is best for the Company to achieve an appropriate capital structure while still on the OTC Markets so that the cap structure risk is mitigated once on a national exchange. In addition to an increase in the number of our authorized shares, we are seeking shareholder approval for various other matters that will better position the Company for the up-list to a national exchange."

- See more at: http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/preparing-amarantus-list-2h-14-capital-markets-strategy/#sthash.d3PDiNjj.dpuf